Mon, Apr 29, 2024
Volume 16, Issue 6 (Special issue (Nov-Dec) 2022)
mljgoums 2022, 16(6): 13-19 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jamal I, Smita S, Raman R B, Choudhary V, Choubey S, Kumar K. Clinico-Hematological Profile of COVID-19 Patients: A Perspective of the Indian Scenario. mljgoums 2022; 16 (6) :13-19
URL: http://mlj.goums.ac.ir/article-1-1510-en.html
URL: http://mlj.goums.ac.ir/article-1-1510-en.html
Iffat Jamal1 
, Shuchi Smita 2, Ravi Bhushan Raman1 , Vijayanand Choudhary1 , Satyadeo Choubey3 , Kaushal Kumar1
, Shuchi Smita 2, Ravi Bhushan Raman1 , Vijayanand Choudhary1 , Satyadeo Choubey3 , Kaushal Kumar1
1- Department of Hematology- IGIMS Patna, Patna, India
2- Department of Hematology- IGIMS Patna, Patna, India , shuchi.smita123@gmail.com
3- Department of Pulmonary Medicine- IGIMS Patna, Patna, India
2- Department of Hematology- IGIMS Patna, Patna, India , shuchi.smita123@gmail.com
3- Department of Pulmonary Medicine- IGIMS Patna, Patna, India
Abstract: (1500 Views)
Background and objectives: The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, a newly emergent coronavirus, first recognized in Wuhan, China in December 2019. Early identification of laboratory indicators helps in distinguishing severe patients from mild to moderate counterparts and can facilitate medical interventions, thereby lowering the mortality rate. The present study was done to evaluate the role of hematological parameters and basic coagulation parameters in the assessment of the severity of COVID-19.
Methods: This retrospective observational study was done at a tertiary care institute from May 2020 to May 2021. Hematological and coagulation profile was studied in 200 confirmed COVID-19 cases. Data related to age, gender, and clinical features were retrieved from patients’ records. Laboratory findings such as complete blood count neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and coagulation parameters in different categories were compared.
Results: The majority of patients were males (59.5%) and with mild illness (52.5%). Moderate and severe illness was present in 30% and 17.5% of cases, respectively. The frequency of anemia, leucopenia, and thrombocytopenia was 62.5%, 6%, and 5.5%, respectively. Overall neutrophilia was seen in 40.5% of cases, whereas lymphopenia was seen in 39% of cases. Coagulation parameters were also much deranged in moderate and severe cases as compared to mild cases.
Conclusion: The hematopoietic and hemostatic systems are significantly affected by COVID-19. Careful evaluation of laboratory parameters assists clinicians in formulating a tailored treatment approach and in predicting disease severity.
Methods: This retrospective observational study was done at a tertiary care institute from May 2020 to May 2021. Hematological and coagulation profile was studied in 200 confirmed COVID-19 cases. Data related to age, gender, and clinical features were retrieved from patients’ records. Laboratory findings such as complete blood count neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and coagulation parameters in different categories were compared.
Results: The majority of patients were males (59.5%) and with mild illness (52.5%). Moderate and severe illness was present in 30% and 17.5% of cases, respectively. The frequency of anemia, leucopenia, and thrombocytopenia was 62.5%, 6%, and 5.5%, respectively. Overall neutrophilia was seen in 40.5% of cases, whereas lymphopenia was seen in 39% of cases. Coagulation parameters were also much deranged in moderate and severe cases as compared to mild cases.
Conclusion: The hematopoietic and hemostatic systems are significantly affected by COVID-19. Careful evaluation of laboratory parameters assists clinicians in formulating a tailored treatment approach and in predicting disease severity.
Research Article: Research Article |
Subject:
Pathology
Received: 2022/04/30 | Accepted: 2022/07/9 | Published: 2022/11/25 | ePublished: 2022/11/25
Received: 2022/04/30 | Accepted: 2022/07/9 | Published: 2022/11/25 | ePublished: 2022/11/25
References
1. World Health Organization. Coronavirus disease (COVID-19): situation report. Vol. 188. Geneva: World Health Organization, 2020. [View at Publisher]
2. Rothan HA and Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109: 102433. [View at Publisher] [DOI:10.1016/j.jaut.2020.102433] [PubMed] [Google Scholar]
3. Long B, Brady WJ, Koyfman A, et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020; 38: 1504-1507. [View at Publisher] [DOI:10.1016/j.ajem.2020.04.048] [PubMed] [Google Scholar]
4. Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020; 82(5): e177. [View at Publisher] [DOI:10.1016/j.jaad.2020.03.036] [PubMed] [Google Scholar]
5. Dawood QM, Al-Hashim TZ ,Basim AA et al. Study of hematological parameters in patients with coronavirus disease 2019 in Basra.Iraqi Journal of Hematology 2020:160-65. [View at Publisher] [DOI:10.4103/ijh.ijh_49_20] [Google Scholar]
6. Bhuiyan Minz, Giti S,Hossen MSM, Rahman MM et al. Haenatologic profile abnormalities and Coagulopathy associated with COVID-19 .A prospective Study of 100 patients.Journal of Bangladesh College of Physicians and Surgeons. 2020; 38: 61-66. [View at Publisher] [DOI:10.3329/jbcps.v38i0.47347]
7. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M,Kitas GD. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med. 2019;39:345-357. [DOI:10.3343/alm.2019.39.4.345] [PubMed] [Google Scholar]
8. Omran S Habib, Abbas K AlKanan, Aِlaa H Abed, Nihad QMohammed. Epidemiological Features of COVID-19 Epidemic in Basrah-Southern Iraq-First Report.The Medical Journal of BasrahUniversity. 2020; 38(1): 7-18. [View at Publisher] [DOI:10.33762/mjbu.2020.126943.1008] [Google Scholar]
9. Akboga MK, Canpolat U, Yuksel M, et al. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: a single center large-scale study. Platelets 2016; 27: 178-183. [View at Publisher] [DOI:10.3109/09537104.2015.1064518] [PubMed] [Google Scholar]
10. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d‑NLR and PLR in COVID‑19 patients. Int Immunopharmacol. 2020; 84:106504. [View at Publisher] [DOI:10.1016/j.intimp.2020.106504] [PubMed] [Google Scholar]
11. Huang S, Liu M, Li X, Shang Z, Zhang T, Hongzhou LU.Significance of Neutrophil‑to‑Lymphocyte Ratio, Platelet‑to Lymphocyte Ratio for Predicting Clinical Outcomes in COVID‑19. China; 2020:1-14. [View at Publisher] [DOI:10.1101/2020.05.04.20090431]
12. Araya S, Wordofa M, Mamo MA, Tsegay YG, Hordofa A et al. The magnitude of Hematological abnormalities among COVID-19 patients in Addis Ababa, Ethiopia.Journal of Multidisciplinary healthcare. 2021;14: 545-554. [View at Publisher] [DOI:10.2147/JMDH.S295432] [PubMed] [Google Scholar]
13. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al.Clinical findings in a group of patients infected with the 2019novel coronavirus (SARS‑Cov‑2) outside of Wuhan, China: Retrospective case series. BMJ. 2020; 368:606. [View at Publisher] [DOI:10.1136/bmj.m606] [PubMed] [Google Scholar]
14. Eastin C, Eastin T. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China: Dong Y, Mo X, Hu Y, et al. Pediatrics. 2020; doi: 10.1542/peds.2020-0702. J Emerg Med. 2020; 58(4): 712–3. [DOI:10.1016/j.jemermed.2020.04.006] [Google Scholar]
15. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020 Mar 17;9(1):29. [View at Publisher] [DOI:10.1186/s40249-020-00646-x] [PubMed] [Google Scholar]
16. Al Hijaj BA, Al‑Rubaye AK, Al‑Hashim ZT, Mohammed MA,Habib OS. A study on 696 COVID‑19 cases in Basrah‑southernIraq: Severity and outcome indicators. Iraqi Natl J Med. 2020;2:27-37. [View at Publisher] [DOI:10.37319/iqnjm.2.CSI.3] [Google Scholar]
17. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID‑19) infections: A meta‑analysis. Clin Chim Acta. 2020; 506:145‑8. [View at Publisher] [DOI:10.1016/j.cca.2020.03.022] [PubMed] [Google Scholar]
18. Fan BE, Chong VC, Chan SS, Lim GH, Lim KG, Tan GB, et al.Hematologic parameters in patients with COVID‑19 infection.Am J Hematol. 2020; 95: 131‑4. [View at Publisher] [DOI:10.1002/ajh.25774] [PubMed] [Google Scholar]
19. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, , et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020; 323: 1612-14. [View at Publisher] [DOI:10.1001/jama.2020.4326] [PubMed] [Google Scholar]
20. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71:762-768. [View at Publisher] [DOI:10.1093/cid/ciaa248] [PubMed] [Google Scholar]
21. Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, et al. A tool to early predict severe 2019-novel coronavirus pneumonia (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clinical Infectious Diseases. 2020; 71(15): 833-840.31. [DOI:10.1093/cid/ciaa443] [PubMed] [Google Scholar]
22. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al.Early transmission dynamics in Wuhan, China, of novel coronavirus‑infected pneumonia. Engl J Med. 2020; 382: 1199. [View at Publisher] [DOI:10.1056/NEJMoa2001316] [PubMed]
23. Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, et al. Clinical characteristics of 82 death cases with COVID-19. PLoS ONE. 2020;15(7). [View at Publisher] [DOI:10.1371/journal.pone.0235458] [PubMed] [Google Scholar]
24. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71: 762-768. [View at Publisher] [DOI:10.1093/cid/ciaa248] [PubMed] [Google Scholar]
25. Bellmann-Weiler R, Lanser L, Barket R, et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. J Clin Med. 2020;9(8):2429.33 [View at Publisher] [DOI:10.3390/jcm9082429] [PubMed] [Google Scholar]
26. Tao Z, Xu J, Chen W, Yang Z, Xu X, Liu L, et al. Anemia is associated with severe illness in COVID-19: A retrospective cohort study. J Med Virol. 2021;93: 1478-1488. [View at Publisher] [DOI:10.1002/jmv.26444] [PubMed] [Google Scholar]
27. Cai SH, Liao W, Chen SW, Liu LL, Liu SY, Zheng ZD. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2. Infect Dis Poverty. 2020;9:80. [View at Publisher] [DOI:10.1186/s40249-020-00703-5] [PubMed] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.